BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35385727)

  • 21. Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model.
    Sontakke P; Carretta M; Jaques J; Brouwers-Vos AZ; Lubbers-Aalders L; Yuan H; de Bruijn JD; Martens AC; Vellenga E; Groen RW; Schuringa JJ
    Leukemia; 2016 Oct; 30(10):2064-2073. PubMed ID: 27125308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells.
    Macanas-Pirard P; Quezada T; Navarrete L; Broekhuizen R; Leisewitz A; Nervi B; Ramírez PA
    PLoS One; 2017; 12(1):e0168888. PubMed ID: 28045930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy is dispensable for Kmt2a/Mll-Mllt3/Af9 AML maintenance and anti-leukemic effect of chloroquine.
    Chen X; Clark J; Wunderlich M; Fan C; Davis A; Chen S; Guan JL; Mulloy JC; Kumar A; Zheng Y
    Autophagy; 2017 May; 13(5):955-966. PubMed ID: 28282266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.
    Sasca D; Szybinski J; Schüler A; Shah V; Heidelberger J; Haehnel PS; Dolnik A; Kriege O; Fehr EM; Gebhardt WH; Reid G; Scholl C; Theobald M; Bullinger L; Beli P; Kindler T
    Blood; 2019 May; 133(21):2305-2319. PubMed ID: 30814062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.
    Ishikawa F; Yoshida S; Saito Y; Hijikata A; Kitamura H; Tanaka S; Nakamura R; Tanaka T; Tomiyama H; Saito N; Fukata M; Miyamoto T; Lyons B; Ohshima K; Uchida N; Taniguchi S; Ohara O; Akashi K; Harada M; Shultz LD
    Nat Biotechnol; 2007 Nov; 25(11):1315-21. PubMed ID: 17952057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
    Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
    Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Liu J; Guo B; Chen Z; Wang N; Iacovino M; Cheng J; Roden C; Pan W; Khan S; Chen S; Kyba M; Fan R; Guo S; Lu J
    Blood; 2017 Mar; 129(11):1491-1502. PubMed ID: 28053194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myeloid leukemia in the vascular niche.
    Cogle CR; Bosse RC; Brewer T; Migdady Y; Shirzad R; Kampen KR; Saki N
    Cancer Lett; 2016 Oct; 380(2):552-560. PubMed ID: 25963886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.
    Zhao N; Pei SN; Qi J; Zeng Z; Iyer SP; Lin P; Tung CH; Zu Y
    Biomaterials; 2015 Oct; 67():42-51. PubMed ID: 26204224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming.
    Bhanot H; Weisberg EL; Reddy MM; Nonami A; Neuberg D; Stone RM; Podar K; Salgia R; Griffin JD; Sattler M
    Oncotarget; 2017 Sep; 8(40):67639-67650. PubMed ID: 28978059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
    Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
    Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease.
    Risueño RM; Campbell CJ; Dingwall S; Levadoux-Martin M; Leber B; Xenocostas A; Bhatia M
    Blood; 2011 Jun; 117(26):7112-20. PubMed ID: 21562049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficient proliferation and expansion in vitro of two bone marrow cell populations from patients with acute myeloid leukemia in response to hematopoietic cytokines.
    Montesinos JJ; Sánchez-Valle E; Flores-Figueroa E; Martínez-Jaramillo G; Flores-Guzmán P; Miranda-Peralta E; Gutiérrez-Romero M; Mayani H
    Leuk Lymphoma; 2006 Jul; 47(7):1379-86. PubMed ID: 16923572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the bone marrow vascular niche in chemotherapy for MLL-AF9-induced acute myeloid leukemia.
    Xu C; Lu T; Lv X; Cheng T; Cheng H
    Blood Sci; 2023 Apr; 5(2):92-100. PubMed ID: 37228781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells.
    Glait-Santar C; Desmond R; Feng X; Bat T; Chen J; Heuston E; Mizukawa B; Mulloy JC; Bodine DM; Larochelle A; Dunbar CE
    Stem Cells; 2015 Dec; 33(12):3635-42. PubMed ID: 26388434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential niche and Wnt requirements during acute myeloid leukemia progression.
    Lane SW; Wang YJ; Lo Celso C; Ragu C; Bullinger L; Sykes SM; Ferraro F; Shterental S; Lin CP; Gilliland DG; Scadden DT; Armstrong SA; Williams DA
    Blood; 2011 Sep; 118(10):2849-56. PubMed ID: 21765021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
    Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
    Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia.
    Henkenius K; Greene BH; Barckhausen C; Hartmann R; Märken M; Kaiser T; Rehberger M; Metzelder SK; Parak WJ; Neubauer A; Brendel C; Mack E
    Leuk Res; 2017 Nov; 62():56-63. PubMed ID: 28985623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting MTHFD2 in acute myeloid leukemia.
    Pikman Y; Puissant A; Alexe G; Furman A; Chen LM; Frumm SM; Ross L; Fenouille N; Bassil CF; Lewis CA; Ramos A; Gould J; Stone RM; DeAngelo DJ; Galinsky I; Clish CB; Kung AL; Hemann MT; Vander Heiden MG; Banerji V; Stegmaier K
    J Exp Med; 2016 Jun; 213(7):1285-306. PubMed ID: 27325891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.